[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100415302":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":27,"responsibleParty":49,"collaborators":7,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":7,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":7,"enrollmentInfo":60,"targetDuration":7,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":7,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Hospices Civils de Lyon","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Biobank","For each patient included in the study the following samples will be collected at the indicated time points after transplantation:\n\n* Serum samples and plasma sample: Day1, Month 1, Month 3, Month 6, Month 12, month 60, month 120 and at the time of each allograft biopsy.\n* Urines samples: Month 3 and Month 12 and at the time of each allograft biopsy.\n* Peripheral Blood Mononuclear Cell (PBMC): for each organ allograft biopsy.\n* Allograft biopsies: systematically at Month 3, and Month 12, and for cause in case of allograft dysfunction.",[13],{"name":14,"affiliation":15,"role":16},"Olivier Thaunat, MD","Edouard Herriot Hospital - Transplantation department","PRINCIPAL_INVESTIGATOR",[18,23],{"name":14,"role":19,"phone":20,"phoneExt":21,"email":22},"CONTACT","04 72 11 69 28","+33","olivier.thaunat@chu-lyon.fr",{"name":24,"role":19,"phone":25,"phoneExt":21,"email":26},"Emmanuel Morelon, MD","04 72 11 01 70","emmanuel.morelon@chu-lyon.fr",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Hopital Edouard Herriot","RECRUITING","Lyon","Rhône","69003","France","FR",{"type":37,"coordinates":38},"Point",[39,40],4.84789,45.74906,{"lat":40,"lon":39},[43,46],{"name":44,"role":19,"phone":45,"phoneExt":21,"email":22},"Olivier THAUNAT, MD","04.72.11.69.28",{"name":47,"role":19,"phone":45,"phoneExt":21,"email":48},"DANIEL SPERANDO, CRA","daniel.sperando@chu-lyon.fr",{"type":50,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100415302","constitution-of-a-biobank-for-studies-related-to-organ-transplantation-lyon-centaure-biocollection-100415302",false,"NCT04687865","Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)","Biological Material Bank for Studies Related to Organ Transplantation","Inclusion Criteria:\n\n* Male or Female patient ≥18 years old\n* Recipient of an organ transplant\n* Written informed consent\n\nExclusion Criteria:\n\n* Non-affiliation to a social security system.\n* Subjects deprived of liberties\n* Pregnant or breastfeeding woman","ALL","18 Years",{"count":61,"type":62},4000,"ESTIMATED","OBSERVATIONAL","This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order :\n\ni) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)",[66],"Organ Transplantation","2025-03-06",{"date":69,"type":70},"2025-03-07","ACTUAL",{"date":72,"type":70},"2020-01-08",{"date":74,"type":62},"2040-01-08",{"name":5,"class":6},1]